Modeling the Impact of Modified Directly Observed Antiretroviral Therapy on HIV Suppression and Resistance, Disease Progression, and Death

Kagay, C. R.; Porco, T. C.; Liechty, C. A.; Chariebois, E.; Clark, R.; Guzman, D.; Moss, A. R.; Bangsberg, D. R.
June 2004
Clinical Infectious Diseases;6/1/2004 Supplement, Vol. 38, pS414
Academic Journal
A simulation model that used Markov assumptions with Monte Carlo uncertainty analysis was evaluated 1500 times at 10,000 iterations. Modified directly observed therapy (MDOT) for human immunodeficiency virus was assumed to improve adherence to therapy to 90% of prescribed doses. The impact of MDOT interventions on modeled biological and clinical outcomes was compared for populations with mean rates of adherence (i.e., the mean percentage of prescribed doses taken by each member of the population who had not discontinued therapy) of 40%, 50%, 60%, and 70%. MDOT reduced the risk of virological failure, development of opportunistic infections, and death, yet increased the risk of drug resistance, for each adherence distribution among persons with detectable plasma virus loads. Over 1500 trials, for a population with 50% adherence to therapy and a 12-month period, MDOT increased the median rate of virological suppression from 13.2% to 37.0% of patients, decreased the rate of opportunistic infection from 5.7% to 4.3% of patients, and decreased the death rate from 2.9% to 2.2% of patients. In the same population, however, MDOT increased the rate of new drug resistance mutations from 1.00 to 1.41 per person during the 12-month period. The impact of MDOT was smaller in populations with higher levels of adherence. MDOT interventions will likely improve clinical outcomes in populations with low levels of adherence but may not be effective at preventing drug resistance in treatment-experienced populations. MDOT may be more effective in preventing drug resistance with potent regimens in treatment-naive patients.


Related Articles

  • Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997–2011. Bontell, Irene; Häggblom, Amanda; Bratt, Göran; Albert, Jan; Sönnerborg, Anders // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Objective: Describe trends in antiretroviral treatments and drug resistance mutations among Swedish HIV-patients over time 1997–2011. Methods: Treatment histories, viral sequences, and demographic and clinical data were retrieved from the national database InfCareHIV. All...

  • HIV-1 Drug-Resistance Surveillance among Treatment-Experienced and -Naïve Patients after the Implementation of Antiretroviral Therapy in Ghana. Nii-Trebi, Nicholas I.; Ibe, Shiro; Barnor, Jacob S.; Ishikawa, Koichi; Brandful, James A. M.; Ofori, Sampson B.; Yamaoka, Shoji; Ampofo, William K.; Sugiura, Wataru // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background: Limited HIV-1 drug-resistance surveillance has been carried out in Ghana since the implementation of antiretroviral therapy (ART). This study sought to provide data on the profile of HIV-1 drug resistance in ART-experienced and newly diagnosed individuals in Ghana. Methods: Samples...

  • Intensive Tuberculosis Screening for HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa. Bassett, Ingrid V.; Wang, Bingxia; Chetty, Senica; Giddy, Janet; Losina, Elena; Mazibuko, Matilda; Bearnot, Benjamin; Allen, Jenny; Walensky, Rochelle P.; Freedberg, Kenneth A. // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, p823 

    Background. The World Health Organization (WHO) recommends cough as the trigger for tuberculosis screening in human immunodeficiency virus (HIV)-infected patients, with acid-fast bacillus (AFB) smear as the initial diagnostic test. Our objective was to assess the yield and cost of a more...

  • More action needed to prevent HIV-associated TB.  // Infectious Disease News;Jun2010, Vol. 23 Issue 6, p20 

    The article discusses research on the need for more frequent testing for HIV infection and the early initiation of antiretroviral treatment, by A. D. Harries and colleagues, published in "Lancet."

  • Clinical digest. Increased HIV testing and anti-retroviral therapy has had negligible effect so far.  // Nursing Standard;2/6/2013, Vol. 27 Issue 23, p14 

    The article discusses research which was reported in the article "HIV Incidence in Men Who Have Sex With Men in England and Wales 2001-10: A Nationwide Population Study" by P. J. Birrell et al. and found that despite an increase in HIV testing and anti-retroviral therapy the number of HIV cases...

  • HIV Responses in Arab States on the Southern Persian Gulf Border: The First Review. Moradi, Afsaneh; Alammehrjerdi, Zahra; Daneshmand, Reza; Amini-Lari, Mahmood; Zarghami, Mehran; Dolan, Kate // Iranian Journal of Psychiatry & Behavioral Sciences;Sep2016, Vol. 10 Issue 3, p1 

    Context: There is no review of HIV responses in Arab states on the southern Persian Gulf border. This narrative review aimed to describe and synthesize HIV responses in Kuwait, Qatar, Bahrain and the United Arab Emirates (UAE). Evidence Acquisition: A review of scientific databases and grey...

  • Improved Virological Outcomes in British Columbia Concomitant with Decreasing Incidence of HIV Type 1 Drug Resistance Detection. Gill, Vikram S.; Lima, Viviane D.; Wen Zhang; Wynhoven, Brian; Yip, Benita; Hogg, Robert S.; Montaner, Julio S. G.; Richard Harrigan, P. // Clinical Infectious Diseases;1/1/2010, Vol. 50 Issue 1, p98 

    Background. There have been limited studies evaluating temporal changes in the incidence of detection of drug resistance among human immunodeficiency virus type 1 (HIV-1) isolates and concomitant changes in plasma HIV load for treated individuals in a population-wide setting. Methods....

  • The influence of antiretroviral therapy on the uptake of HIV testing in Tutume, Botswana. Warwick, Zoe // International Journal of STD & AIDS;Jul2006, Vol. 17 Issue 7, p479 

    This paper describes how the national antiretroviral (ARV) programme in Botswana has influenced the willingness of the community of Tutume District, Botswana to come forward for HIV testing. A retrospective review of Tutume Primary Hospital records was performed for three different periods:...

  • Incidence of Kaposi Sarcoma in HIV-infected patients - a prospective multi-cohort study from Southern Africa. Bohlius, Julia; Valeri, Fabio; Maskew, Mhairi; Prozesky, Hans; Chimbetete, Cleophas; Lumano-Mulenga, Priscilla; Garone, Daniela; Gsponer, Thomas; Egger, Matthias // Infectious Agents & Cancer;2012 Supplement 1, Vol. 7 Issue Suppl 1, p1 

    The article presents a study which investigates the incidence of Kaposi Sarcoma (KS) among patients with HIV infection in Southern Africa. Data from the multi-cohort project International epidemiologic Database to Evaluate AIDS (IeDEA) are outlined. The study concludes that the risk of KS...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics